Status:

COMPLETED

Communicating a Cancer Diagnosis-Current Methods and Their Effects

Lead Sponsor:

National Institutes of Health Clinical Center (CC)

Conditions:

Behavior

Cancer

Eligibility:

All Genders

18-100 years

Brief Summary

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: * Distinguish m...

Detailed Description

Background: \- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs. Obj...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Age greater than or equal to 18 years.
  • A patient diagnosed with cancer who is either currently enrolled in a protocol and receiving treatment or has come to NCI for consult and potential enrollment in a trial.
  • Ability to follow basic verbal instructions as observed by either an investigator of the study or as reported by a member of the patient's primary clinical team.
  • Patient must comprehend English, verbal and written, to be determined by the investigator distributing the questionnaire.
  • Patients with a hearing and/or visual impairment will be eligible to participate in the study if they so choose. Appropriate accommodations will be made.
  • Signed informed consent form.
  • EXCLUSION CRITERIA:
  • Patients that have cognitive impairments, such as mental challenges/retardation due to a congenital or developmental anomaly.
  • a. Subjects with cognitive impairments are ineligible to participate in the study due to comprehension inabilities.
  • Patients who have developed dementia as a result of their disease or from an unspecified source are not eligible for participation due to both memory and overall cognitive deficits.
  • Patients that have multiple concurrent cancers are excluded from participation in this study.

Exclusion

    Key Trial Info

    Start Date :

    April 24 2008

    Trial Type :

    OBSERVATIONAL

    End Date :

    July 16 2009

    Estimated Enrollment :

    1100 Patients enrolled

    Trial Details

    Trial ID

    NCT00674804

    Start Date

    April 24 2008

    End Date

    July 16 2009

    Last Update

    July 2 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892